Tag: Adaptimmune Therapeutics

Cell and Gene Therapy, Industry

Adaptimmune’s TCR T-cell therapy clears efficacy bar in rare cancers, teeing up landmark solid tumor filing

November 12, 2021

Via: FierceBiotech

Adaptimmune Therapeutics is on track to bring the first engineered T-cell therapy to market in a solid tumor indication. With the response rate above the target threshold at the interim analysis, the biotech is certain the study will hit its […]